Company / Working Capital
Indivior Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$262.0M
FY2025
5-year range
-$262.0M / -$24.0M
FY2023-FY2025
Trend
-170.1%
vs FY2024
Sector context
#212 of 213
Health Care
What the data says
Among 213 Health Care companies, Indivior is in the bottom 0% for working capital. Declined from -$24M to -$262M over the past 2 years.
Based on SEC 10-K filings.
-$262M in FY2025.
Declined from -$24M to -$262M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 213This company -$262.0M Sector average $934.6M
▼
-128.0% below sector average
Key checks
Key Insights
- In FY2025, working capital decreased 170.1% year-over-year.
- Ranks #212 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$262.0M | -170.1% |
| FY2024 | -$97.0M | -304.2% |
| FY2023 | -$24.0M | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026